Blood test study to track markers in diabetes
Part of Hormones & metabolism clinical trials.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can (or your guardian can) sign informed consent/assent to join
- You’re in one of these groups: type 1 diabetes, adult type 2 diabetes, antibody-positive people without diabetes (certain A1c range), or adults with prediabetes or low A1c as a control
- Your weight is at least 30 kg
- You’re willing to provide blood samples (up to about 100 mL if applicable) and allow review of medical records or lab results
- You do not have key exclusions like active infection or currently treated cancer
- You haven’t had certain immune-modifying treatments in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your diet affects blood sugar spikes after meals. You will wear a small sensor that tracks your glucose for a short time, and you will keep a record of what you eat so the research team can see which foods may lead to higher or lower blood sugar.
This study follows up with people who took part in an earlier diabetes study called GLUTADIAB. The goal is to see how their health has changed over time, which may help improve diabetes care.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
This study looks at how your immune system changes over time and how that relates to developing type 1 diabetes. You may be able to join if you can have blood drawn, since the study focuses on blood samples.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.